{"success":true,"data":{"pressRelease":{"id":"47960","rtpr_id":"nGNX3HkdTG","ticker":"LXRX","exchange":"NASDAQ","all_tickers":["LXRX"],"title":"Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference","author":"Globe Newswire","published_at":"2026-05-28T12:30:00.374Z","article_body":"THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon\nPharmaceuticals, Inc.\n(https://www.globenewswire.com/Tracker?data=Jg-AJURJmAVl73VhxWU7Kgpw_WTIQdGtHGnYgKDyV_aIigVUkXhhNvBbTTV6QOfDm1VY_KoUJeAvJbhTP-amCi2FHQ0frXMP4ryLW4BogG3x_ywbXwSRNxpieF84UibZgkS82s1Zbpoz4bUwD7JJp4pN6kpTSKSM5clwftPi4jh3NjcCUF4JwtuTmPCV10VePDQn5UqQcjIYUoYTFtIrLOP6k_4XWEE5ELecdRWyjoDNBt2naEbuC0DkcUPTMpuXtP8HM4lYdy1oluXvbg5evj-7kkGzDg2BoOjdaNL9CLSWoiOk_vAR6vGcuUmi8wYu) (Nasdaq:\nLXRX) today announced that Company management will participate in a fireside\nchat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at\n2:00 p.m. ET in New York City.\n\nThe live event and a replay of the presentation can be accessed via the Events\npage of the Company’s website at https://investors.lexpharma.com/.\n\nAbout Lexicon Pharmaceuticals    \nLexicon is a biopharmaceutical company with a mission of pioneering medicines\nthat transform patients’ lives. Lexicon has a pipeline of drug candidates in\ndiscovery, preclinical, and clinical development in neuropathic pain,\nhypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and\nother cardiometabolic indications. For additional information, please\nvisit www.lexpharma.com.   \n\nFor Media Inquiries: \nDave Belian \nLexicon Pharmaceuticals, Inc. \nlexinvest@lexpharma.com  \n  \nFor Investor Inquiries: \nLisa DeFrancesco \nLexicon Pharmaceuticals, Inc. \nlexinvest@lexpharma.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/afcf3b59-ca71-40ed-9226-a0901bf4d13b)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX3HkdTG","title":"Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference","author":"Globe Newswire","ticker":"LXRX","created":"2026-05-28T12:30:00.374Z","tickers":["LXRX"],"exchange":"NASDAQ","article_body":"THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon\nPharmaceuticals, Inc.\n(https://www.globenewswire.com/Tracker?data=Jg-AJURJmAVl73VhxWU7Kgpw_WTIQdGtHGnYgKDyV_aIigVUkXhhNvBbTTV6QOfDm1VY_KoUJeAvJbhTP-amCi2FHQ0frXMP4ryLW4BogG3x_ywbXwSRNxpieF84UibZgkS82s1Zbpoz4bUwD7JJp4pN6kpTSKSM5clwftPi4jh3NjcCUF4JwtuTmPCV10VePDQn5UqQcjIYUoYTFtIrLOP6k_4XWEE5ELecdRWyjoDNBt2naEbuC0DkcUPTMpuXtP8HM4lYdy1oluXvbg5evj-7kkGzDg2BoOjdaNL9CLSWoiOk_vAR6vGcuUmi8wYu) (Nasdaq:\nLXRX) today announced that Company management will participate in a fireside\nchat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at\n2:00 p.m. ET in New York City.\n\nThe live event and a replay of the presentation can be accessed via the Events\npage of the Company’s website at https://investors.lexpharma.com/.\n\nAbout Lexicon Pharmaceuticals    \nLexicon is a biopharmaceutical company with a mission of pioneering medicines\nthat transform patients’ lives. Lexicon has a pipeline of drug candidates in\ndiscovery, preclinical, and clinical development in neuropathic pain,\nhypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and\nother cardiometabolic indications. For additional information, please\nvisit www.lexpharma.com.   \n\nFor Media Inquiries: \nDave Belian \nLexicon Pharmaceuticals, Inc. \nlexinvest@lexpharma.com  \n  \nFor Investor Inquiries: \nLisa DeFrancesco \nLexicon Pharmaceuticals, Inc. \nlexinvest@lexpharma.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/afcf3b59-ca71-40ed-9226-a0901bf4d13b)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-28T12:30:00.413886411Z","server_sent_at_ms":1779971400413},"received_at":"2026-05-28T12:30:00.604Z","source_url":null},"analysis":{"id":"37391","press_release_id":"47960","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Lexicon Pharmaceuticals management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference.\n\nThe event is scheduled for June 4, 2026, at 2:00 p.m. ET in New York City.\n\nA live stream and replay will be available on the company's investor relations website.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference appearance -- monitor for any ad-hoc data drops during the session."},"keyFigures":{},"quotedText":"Company management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 2:00 p.m. ET in New York City.","namedEntities":{"people":[{"name":"Dave Belian","role":"Media Contact"},{"name":"Lisa DeFrancesco","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"Lexicon Pharmaceuticals, Inc.","ticker":"LXRX"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine conference participation announcement. No new clinical data, financial results, or strategic developments disclosed. Standard investor relations activity."},"tickerRelevance":{"others":[{"ticker":"JEF","relevance":"conference organizer"}],"primary":"LXRX"},"globalImportance":15,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"routine_ir","sectorWeight":"healthcare","householdBrandBoost":0,"retailFavoriteBoost":0}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Lexicon Pharmaceuticals management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference.\n\nThe event is scheduled for June 4, 2026, at 2:00 p.m. ET in New York City.\n\nA live stream and replay will be available on the company's investor relations website.","key_figures":{},"named_entities":{"people":[{"name":"Dave Belian","role":"Media Contact"},{"name":"Lisa DeFrancesco","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"Lexicon Pharmaceuticals, Inc.","ticker":"LXRX"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-28T12:34:24.349Z","global_importance":15,"audience_relevance":20,"importance_components":{"tickerTier":"mid-cap","eventGravity":"routine_ir","sectorWeight":"healthcare","householdBrandBoost":0,"retailFavoriteBoost":0}},"durationMs":37421,"modelName":"george-droid-qwen-72b"}}